Mauro Schechter

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Faculdade de Medicina

Departamento:

Departamento de Medicina Preventiva/FM

ORCID:

não disponível no Lattes


Formação:
  • Rockefeller University

    | Pós-Doutorado | 1986 - 1988
  • University of London

    Clinical Tropical Medicine | Doutorado | 1981 - 1985
  • University of London

    Clinical Tropical Medicine | Mestrado | 1980 - 1981
  • Universidade Federal do Rio de Janeiro

    Doenças Infecciosas e Parasitárias | Especialização | 1978 - 1979
  • Universidade Federal do Rio de Janeiro

    Medicina | Graduação | 1971 - 1977
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:
Nenhum artigo cadastrado
Eventos:

(0.00% eventos com DOI)

Titulo DOI Ano
iPrEx Study Team. Results of the iPrEx open-label extension (iPrEx OLE) in men and transgender women who have sex with men: PrEP uptake, sexual practices, and HIV incidence 2014
Patterns and Correlates of PrEP Drug Detection among MSM and Transgender Women in the Global iPrEx Study 2014
iPrEx Study Team. Drug detection during open-label extension of the iPrEx trial indicates sustained and appropriate interest in PrEP among men who have sex with men 2014
Changes in Renal Function during Use of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis: iPrEx 2013
Drug detection during open-label extension of the iPrEx trial indicates sustained and appropriate interest in PrEP among men who have sex with men. 2013
Efficacy and Safety of Raltegravir Among Latin American Patients in STARTMRK. 2013
Mortality in Patients with Well-controlled HIV and High CD4 Counts in the cART Arms of the SMART and ESPRIT Randomized Clinical Trials Compared to the General Population 2012
Interleukin-6 and D-dimer at HIV Seroconversion as Predictors of HIV Disease Progression 2012
Antiviral Efficacy of Entecavir in Black/African American and Hispanic Patients with Chronic Hepatitis B who are Nucleos(t)ide-Naïve 2012
Prioritizing PrEP among MSM for Greatest Efficacy: An Analysis of the iPrEx Data 2012
Oral TDF and Its Impact in HSV-2 Acquisition and Clinical Expression 2011
Local risk indicators key for targeting PrEP. 2011
Completed observation of the randomized placebo-controlled phase of iPrEx: daily oral FTC/TDF pre-exposure HIV prophylaxis among men and trans women who have sex with men 2011
Hepatic Safety and Tolerability of Etravirine: Pooled 96-week Analysis of DUET-1 and DUET-2 2010
A Comparison of HIV Viral Rebound following ART Cessation in Primary and Chronic HIV Infection 2010
Prediction of CD4 cell count slope in patients with virological failure to first-line of antiretroviral combinations in resource-limited settings 2009
Using the yearly proportion of patients with undetectable viral load - a WHO indicator of HAART effectiveness - in a middle-income country 2009
Differences in heath-related quality of life (HRQL) measured by the PROQOL-HIV, a new specific instrument developed across cultures 2009
HIV/AIDS clinical mentoring results in increased access to trained health workers and improved care 2009
Correcting mortality for loss to follow up: a graphical approach applied to ART programmes in resource-limited settings 2009
Psychometric validation of PROQOL-HIV a contemporaneous and cross-cultural health-related quality-of-life (HRQL) questionnaire specificific 2009
Comparison of WHO vs CDC staging system in predicting mortality at 2 years of HAART HIV-1 infected adults initiating treatment in resource-constrained countries 2009
Prioritising prevention strategies for patients in antiretroviral treatment programmes in resource-limited settings 2009
48-Week Results from BENCHMRK-2, a Phase III Study of Raltegravir in Patients Failing ART with Triple-class Resistant HIV 2008
Mortality of HIV-1-infected Patients Starting ART in Sub-Saharan Africa: The IeDEA Prognostic Model 2008
Effect of Early Immunovirologic Discordant Responses on Mortality in Naïve HIV-1-infected Adults Initiating Treatment in Resource-constrained Countries 2008
Mortality during the first year of potent antiretroviral therapy in HIV-1-Infected patients from 5 treatment centers in the Caribbean and Latin America 2008
Reasons for change of first potent antiretroviral therapy in HIV-1-Infected patients in 5 sites throughout the Caribbean and Latin America 2008
Underreporting deaths among HIV-Infected/AIDS patients in Rio de Janeiro, Brazil 2008
Incidence and severity of nervous system and psychiatric events are similar with etravirine (TMC125, ETR) versus placebo: pooled 48-week date from the phase III DUET studies 2008
Results of BENCHMRK-2, a Phase III Study Evaluating the Efficacy and Safety of MK-0518, a Novel HIV-1 Integrase Inhibitor, in Patients with Triple-class Resistant Virus 2007
Significant increases in cardiovascular diseases and diabetes as causes of death in HIV-infected individuals in the HAART era in Brazil: a population based analysis 2007
Risk Factors for Recent HIV-1 Infection at an HIV Testing Site in Rio de Janeiro, Brazil: A Case-Control Study 2007
96-week efficacy and safety results of simplification to single agent lopinavir/ritonavir (LPV/r) regimen in patients suppressed below 80 copies/mL on HAART - the KalMo study 2007
Identification of Risk Factors for Recent HIV-1 Infection in a HIV Testing Site in Rio de Janeiro, Brazil 2007
Barriers to recruit female commercial sex workers for HIV vaccine trials: The Rio de Janeiro Experience 2007
TMC125 Safety and Tolerability in Treatment-Experienced Hepatitis B or C Co-infected Patients in DUET-1 and DUET-2 2007
When Are Adults in Resource-constrained Settings Most Likely to Experience an HIV-associated Illness following HAART Initiation and What Is It Related To? 2006
Discordant Immunologic and Virologic Responses to ART among Previously Naive Adults Initiating HAART in Resource-constrained Settings 2006
Censoring issues in observational HIV treatment cohorts: describing different approaches to censoring and their effects on estimates of mortality and losses to follow-up in a multinational cohort collaboration from resource-constrained settings 2006
Life expectancy of HIV-infected men and women initiating HAART in resource-constrained settings: insights from the ART-LINC collaboration 2006
Clinical mentoring: tapping into the vast, mostly neglected, western resources to make a fast, sustainable, and effective contribution to putting AIDS patients on ART in developing countries 2006
Relationship of egocentric network characteristics and HIV transmission among MSM in Rio de Janeiro, Brazil 2006
Building and retaining a group of potential volunteers for HIV vaccine trials in Rio de Janeiro, Brazil 2006
48-week efficacy and safety results of simplification to single agent lopinavir/ritonavir (LPV/r) regimen in patients suppressed below 80 copies/mL on HAART - the KalMo study 2006
Response to Highly Active Retroviral Therapy in Low- and High-income Countries: Analysis of Clinical Databases from 4 Continents. 2005
Predictors of Virological Failure at 6 Months of Therapy in HIV-1-infected Patients Starting HAART in Porto Alegre, Brazil 2005
Generic drugs, health delivery mode and effectiveness of HAART in Brazil. 2005
Prognostic value of baseline total lumphocyte count (TLC) vs, absolute CD4 count in predicting survival among patients initiating HAART in low-income countries 2005
Leveraging Western medical expertises to rapidy build healthcare systems for HIV/AIDS in developing countries. 2005
The effectiveness of clinical mentoring as a method to improvee HIV/AIDS clinical skills of healthcare professionais in Cambodia 2005
How do different types of treatment regimens affect short-term response to Highly Active Antiretroviral Treatment (HAART) among adults initiating treatment in low-income countries? 2005
Gender, access and response to potent antiretroviral in low-income countries: ART-LINC Collaboration 2005
Short-term incidence and risk factors for being lost to treatment in 16 antiretroviral treatment cohorts in low income countries 2005
Course of human immunodeficiency virus type 1 infection after seroconversion in a cohort of men who have sex with men (MSM) in Rio de Janeiro, Brazil 2005
Epidemiology of Human Pre-Existing Anti-Adenovirus type-6 and (AD6) and type-5 (AD5) Neutralizing Antibodies (NA) in Areas Representative of Potential HIV Vaccine Trials Sites 2005
HIVNET 026: A Multi-Site International Trial of na HIV-1 Canarypox Vaccine (ALVAC-HIVVCP 1452) With or Without Boosting With MN RGP 120 2005
Study on the feasibility of antiretroviral therapy with a single agent-Lopinavir/r- in patients treated with HAART and with viral load below 80 copies/ml-KalMo. 2005
HIV post-sexual exposure prophylaxis 2004
Factors associated with antiretroviral adherence in public clinics in Rio de Janeiro, Brazil 2004
Morisky questions as a tool to evaluate adherence to antiretroviral therapy in public primary care clinics in Rio de Janeiro, Brazil 2004
Involving community members in HIV vaccine research programs 2004
Poor penetration of lopinavir in the genital tract of men receiving HAART in Brazil. 2004
Genital HIV-1 viral load is correlated with blood plasma HIV-1 viral load in Brazilian women and is reduced by antiretroviral therapy 2004
International epidemiology of human pre-existing anti-adenovirus Type-5 (Ad5) neutralizing antibodies in areas representative of potential HIV vaccine trial sites 2004
Retention of subjects in a multi-site international epidemiology study In preparation of large scale HIV vaccine efficacy trials 2004
Recruitment of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil: Risk profile and willingness to participate in vaccine trials 2004
Characteristics of ART treatment programmes in low-income countries: the ART-LINC collaboration 2004
Recruitment and retention of a high-risk heterosexual cohort for HIV vaccine efficacy trials in Rio de Janeiro, Brazil: risk profile and willingness to participate in vaccine trials 2004
Lipid Changes in a Randomized Comparative Trial of First-line Antiretroviral Therapy with Regimens Containing Either Nevirapine Alone, Efavirenz Alone or Both Drugs Combined, Together with Stavudine and Lamivudine (2NN Study). 2003
Risk Factors for Kaposi?s Sarcoma-associated Herpesvirus Infection among Homosexual Men at Hight Risk for HIV Infection in Brazil 2003
Safer Sex After Initiation of Antiretroviral Therapy in a Public HIV Clinic in Brazil 2003
Risk Factors for HIV and STDs among Young Women Seeking HIV Testing in Rio de Janeiro 2003
Large Scale use of Antiretroviral Drugs is not Associated with a High Prevalence of Genotypic Resistance Mutations in Treatment-Naive HIV-1 Infected Individuals in Rio de Janeiro, Brazil. 2003
Is Natural Selection Involved in the Rapid Expansion of GWGR Subtype B Variant in Brazil? 2003
Identification of a High-Risk Heterosexual Cohort for HIV Vaccine Efficacy Trials in Rio de Janeiro, Brazil 2003
HIV and STI Interactions Among Young Women Seeking HIV Testing in Rio de Janeiro. 2003
International Epidemiology Human Pre-existing Anti-Adenovirus Type-5 (Ad5) Neutralizing Antibodies in Areas Representative of Potential HIV Vaccine Trial Sites. 2003
Conduct of a Mmulti-site HIV Vaccine Trial (HIVNET026) in the Caribbean and South America 2003
Feasibility of Multiside International Epidemiologic Studies in Preparation of Large Scale HIV Vaccine Efficacy Trials 2003
Projeto Praça Onze. Recruitment of a High-risk Heterosexual Cohort for HIV Vaccine Efficacy Trials in Rio de Janeiro, Brazil. 2003
Acceptability, Behaioral Impact, and Possible Efficacy of Post-Sexual-Exposure Chemoprophylaxis (PEP) for HIV 2002
Community participation on HIV vaccine research in Brazil 2002
Effectiveness of antiretrovirais in patients who attend HIV clinics in Rio de Janeiro, Brazil 2002
Frequent presence of polymorphisms in the protease and reverse transcriptase genes of viruses obtained from treatment-naive Brazilian patients 2002
HIV-infected marginalized and abused women from Rio de Janeiro, Brazil are heavily coinfected with HPV but have low/moderate prevalence for other sexually transmitted infections 2002
High HPV viral load associated with advanced immunodeficiency and pre-invasive cervical lesions in HIV infected women in Rio de Janeiro 2002
High prevalence of HIV and sexually transmitted infectious among young women seeking HIV testing in Rio de Janeiro 2002
Non-hodgkin lymphoma associated to HIV infection: a case report 2002
Reactivity of anti-HIV T-cell immune responses to different HIV-1 subtypes among HIV+ individuals from Brazil, Thailand and the US 2002
Sexual Activity after initiation of antiretroviral therapy in Brazil 2002
Abacavir/Combivir (ABC/COM) is Comparable to Indinavir/Combivir in HIV-1 Infected Antiretroviral Therapy Naive Adults: Preliminary Results of a 48-week Open Label Study (CNA3014) 2001
Post-Sexual-Exposure Chemoprophylaxis (PEP) for HIV: A Prospective Cohort Study of Behavioral Impact 2001
Reduced Risk of Tuberculosis (TB) Among Patients with HIV infection Treated with HAART in a Brazilian Cohort 2001
Citomegalovirose no Transplante Renal. Possível Associação com o uso de Micofenolato Mofetil 2001
Dynamics of HIV replication is semen comportament is higher than that in blood compartment 2001
Evidence for Two Different Phylogenetic Distribution patientes of GWGR and GPGR Variants of Subtype B HIV-1 Viruses in Brazil 2001
Infecções por Bactérias Multi-resistentes. Problema Emergente no Transplante Hepático 2001
Behavioral Impact of the Avaliabillity of Post Sexual Exposure Chemoprophylaxis(PEP) for HIV: A prospective Cohort Study 2001
Rebound of Seminal HIV-1 Viral Load Associated with Sexually Transmitted Diseases (STDs) after Virologic Suppression by Antiretroviral Therapy. 2000
Sensitive/Less-Sensitive HIV Testing Strategy to Identify a High-Risk Heterosexual Population in Brazil 2000
Demand for Post-Sexual-Exposure Chemoprophylaxis for the Prevention of HIV Infection in Brazil 2000
Predictors of Seminal Viral Load (SVL) Supression in Subjects Starting Antiretroviral Therapy (ART). 2000
Risk factors for HPV infection in a cohort of HIV-1 infectecd women with a high prevalence of co-infection by oncogenic HPV 2000
Tuberculosis and survival of HIV-infected patients in an area with a high prevalence of M.tuberculosis infection. 2000
Homosexuality and willingness to participate in an HIV vaccine trial. 2000
Acceptability of Post-Sexual-Exposure Chemoprophylaxis for the Prevention of HIV Infection in Brazil 2000
Reduced Risk of Tuberculosis (TB) among Patients with HIV Infection Treated with Highly Active Antiretroviral Therapy (HAART) 2000
Perception of risk and regular partnership among MSM in Rio de Janeiro, Brazil. HPV 2000
Tuberculose (TB) em Receptores de Transplante Renal (RTR) 2000
Seminal HIV-1 Viral Load Is Reduced by Antiretroviral Therapy and Is Correlated with Plasma HIV-1 Viral Load 1999
A High-Incidence Homosexual Male Cohort for Vaccine Trials in Brazil. 1999
V3- Binding Serotypes and HIV Disease Progression in Brazil: Is B Different from B'?. 1999
The Sensitive/Less Sensitive HIV Testing Strategy to Identify a High-Risk Heterosexual Population for HIV Vaccine Trials in Brazil. 1999
Demand for Post- Sexual-Exposure Chemophophylaxis for the Prevention of HIV Infection in Brazil 1999
Seminal HIV-1 Shedding is Increased by the Presence of Genital Warts. 1999
Adherence to Antiretroviral Therapy (ART) is Associated with Seminal Viral Load (SVL) Supression 1999
The absence of a definition of Acute Retroviral Syndrome (ARS) in a Cohot of HIV-Seronegative Homosexual Men in Brazil 1999
Sorotipo da Infecção pelo HIV no Rio de Janeiro 1999
Estudo da Resposta Imune na Coinfecção HTLV-I/HIV 1999
Molecular and epidemiologic evidence for the discontinuous introduction of subtypes B and F into Rio de Janeiro, Brazil 1998
Impact of anti-retroviral therapy on HIV-1 seminal viral load. 1998
Prevalence of markers for sexually transmitted diseases in a male population at high risk for HIV infection 1998
Risk factors for tuberculosis (TB) in a cohort of HIV-infected patients in Rio de Janeiro, Brazil 1998
Unprotected oral sex among men who have sex with men (MSM) 1998
High correlation between plasma and seminal HIV-1 viral load in antiretroviral-naive Brazilian subjects. 1998
Willingness to participate in a vaccine preparatory study in Rio de Janeiro, Brazil 1998
Gender and progression of HIV-associated immunodeficiency. 1998
Sobrevida Após Sida: Estudo Comparativo Entre Sexos. 1997
Incidência de Tuberculose Em Uma Coorte de Pacientes Com Infecção Pelo Vírus da Imunodeficiência Humana 1997
Ausência de Associação Entre O Sistema de Estágios da Oms e Carga Viral do Vírus da Imunodeficiência Humana (Hiv) 1997
Horizontal and Vertical Transmission of HIV-1 Dual Infections Caused by Viruses of Subtypes B and C 1997
HIV viral load and CD4 lymphocyte counts in subjects coinfected with HTLV-1 and HIV-1. 1997
Endocarditis Due to Corynebacterium diphtheriae: Case Report. Fourth International Symposium on Modern Concepts in Endocarditis and Cardiovascular Infections, 1997
Análise do polimorfismo do gene da protease do HIV- 1 em amostras do Rio de Janeiro 1997
Soroprevalência do Herpes simplexvirus em doadores de sangue e em uma população masculina de alto risco para a infecção pelo HIV. 1997
Hiv-1 Infections In Brazil: Single, Duals And Recombinants 1996
Multicentre Evaluation Of Alternative Methods For Cd4 Lynphocyte Determination 1996
Incidence Of Tuberculosis In A Cohort Of Hiv-1 Infected Women In Rio de Janeiro, Brazil. 1996
High Prevalence Of Stds And Hig-Risk Behavior Among Men Who Have Sex With Men In An Hiv Seroincidence Study In Brazil 1996
Recruitment For An Hiv Seroincidence Study In Brazil: Alternative Approaches And Lesson Learned 1996
Willingness Of Participants In An Hiv Seroincidence Study In Rio de Janeiro, Brazil To Participate In Future Vaccine Trials. 1996
Frequency Of Subtypes Of Hiv-1 In Participants Off A Cohort Study In Rio de Janeiro, Brazil, As Suggested By Endonuclease Digestion Patterns Of The Protease Gene. 1996
Differences In The Prevalence Of Hiv-1 Subtypes In Male And Female Participants Of A Cohort Study In Rio de Janeiro, Brazil. 1996
Natural History Of Hiv-1 Infection In Women In Rio de Janeiro, Brazil 1996
Impact Of Antiretroviral Use On Survival In A Large Brazilian Seroprevalent Cohort 1996
Human T-Cell Lymphotropic Virus Type I Does Not Increase Hiv Viral Load In Vivo 1996
Diferenças Na Prevalência de Subtipos de Hiv-1 Entre Homens e Mulheres Participantes de Um Estudo de Coorte No Rio de Janeiro 1996
Impacto do Uso de Anti-Retroviral Na Sobrevida Em Uma Coorte de Pacientes Infectados Pelo Hiv. 1996
Infecção Por Hiv Em Mulheres: Análise Descritiva de Uma Coorte No Rio de Janeiro. 1996
Manifestações Neurológicas Associadas À Coinfecção Hiv/Htlv-1 1996
Prevalência de Marcadores de Doenças Sexualmente Transmissiveis Em Uma População Masculina de Alto Risco Para A Infecção Pelo Hiv 1996
Quantificação da Carga Viral de Hcv e de Hiv Em Pacientes Coinfectados Por Ambos Os Vírus 1996
Validação de Um Teste Rápido Para O Diagnóstico Sorológico Em Uma População Masculina de Alto Risco Para A Infecção Pelo Hiv. 1996
Detection of genetically diverse Human Immunodeficiency Virus Type I group M and O isolates by PCR 1996
Quantitative detection of Hepatitis C virus and Human Immunodeficiency Virus RNA in Brazilian Coinfected Patients. 1996
Coinfecção por HTLV-1 Não Aumenta a Carga Viral de HIV In Vivo. 1996
Incidência de Tuberculose (TB) Em Uma Coorte de Mulheres No Rio de Janeiro. 1996
Impacto do Uso de Anti-Retroviral na Sobrevida em Uma Coorte de Pacientes Infectados Pelo HIV 1996
Confirmation Of Homotypic Dual Infections With Hiv-1 And Phylogenetic Analyses Of The Contributing Subtypes 1995
Immune Diysfunction In Htlv-1 And Hiv Coinfection More Severe Than In Hiv Infection Alone. 1995
Myelopathy Among Brazilians Coinfected With Human T-Cell Lymphotropic Virus Type I And Hiv. 1995
Immune Dysfunction In Htlv-1 And Hiv Coinfection: Results Of A Pilot Study. 1995
Htlv I/Ii Infection In Brazilian Adult Patients With Neurologic Conditions. 1995
Infecção Pelo Virus Herpes Simples Resistente Ao Aciclovir. 1995
Genetic Variation In Protease Gene Of Hiv-1 In Rio de Janeiro 1995
In Vivo T-Cell Dysfunction In Coinfection With Human T-Cell Lymphotropic Virus Type I (Htlv-I) And Hiv. 1995
Characterization Of Hiv-I Dual Infection In Patients Of Rio de Janeiro. 1995
Frequency Of Subtypes Of Hiv-1 In Participants Of A Cohort Study In Rio de Janeiro As Suggested By Endonuclease Digestion Patterns Of The Protease Gene 1995
Differences In The Prevalence Of Hiv-1 Subtypes In Male And Famale Participants Of A Cohort Study In Rio de Janeiro 1995
Myelopathy Among Brazilians Coinfected With Human T-Cell Lymphotropic Virus Type I And Hiv 1995
Fluctuations in culutre of distinct HIV-1 strains from dually infected persons. 1995
Myelopathy Among Brazilians Coinfected With Human T-Cell Lymphotropic Virus Type I and HIV 1995
Identification Of Three Distinct Hiv-1 Subtypes In Brazil Based On The Protease Gene 1994
Reasons For Participating In Clinical Trials In Brazil. 1994
Full Sequence Of Gp120 Of An Hiv-1 Variant (Gwgr) Highly Prevalent In Brazil 1994
Hiv-1/Htlv-1 Coinfection Is Associated With A High Frequency Of Myelopathies. 1994
Heat Versus Acid Dissociation Of Immune Complexes for the detection of p24 antigenia 1994
Hiv-Infected Cells Can Kill Cd4+ Cells Upon Contact. 1994
Hiv-1, Htlv-1 And Tuberculosis Among Intravenous Drug Users In Rio de Janeiro, Brazil 1994
Myelopathy Among Brazilians Coinfected With Human T-Cell Lymphotropic Virus Type I And Hiv. 1994
HTLV-1-related neurologic manifestations among Brazilians subjects co-infected with HTLV-1 and HIV 1994
Full sequence of GP120 of an HIV-1 variant (GWGR) highly prevalent in Brazil 1994
HIV-1 and HTLV-1 infection: A case-control study. 1993
Clinical correlates of NK cell number and activity in HIV positive patients 1993
High prevalence of HIV-1 infection in a representative sample of childbearing women in Rio de Janeiro, Brazil. 1993
Prevalence of antibodies to Hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro. 1993
Natural Killer cell function and number in HIV-1 positive patients: CD16/56+ with CD3- or CD3+ phenotype 1993
Prevalence of HTLV infection among heterosexual couples with HIV positive male index cases 1993
Correlates of p24 antigenemia in HIV-1 infected Brazilian individuals 1993
Correlates of reactivity to V3 loop peptides in HIV-1 infected patients in Rio de Janeiro, Brazil 1993
HIV-1 prevalence in 4536 childbearing women attending maternity wards in Rio de Janeiro: A model based in correspondence analysis 1993
Coinfection with Human T-cell Lymphotropic Virus Type I (HTLV-I) among adults with HIV infection in Brazil 1993
ENMG and SSEP Study in HTLV-1 patients. 1993
HIV-1 and HTLV-1 dual infection: Impact on CD4 counts and clinical stage 1993
Impact of co- infection with HTLV-1 and HIV on markers of HIV disease progression 1993
Antibiotic regimen as an independent risk factor for disseminated fungal infections in neutropenic patients 1993
A frequencia de antigenemia e sua correlacao com criterios evolutivos na infeccao pelo HIV no Brasil 1993
Aleitamento e transmissão vertical do HIV-1 1993
Correlates of p24 antigenemia in HIV-1 infected Brazilian individuals 1993
Prevalence of antibodies to Hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro. 1993
Natural Killer cell function and number in HIV-1 positive patients: CD16/56+ with CD3- or CD3+ phenotype 1993
Clinical correlates of NK cell number and activity in HIV positive patients 1993
Eletroneuromiografia e potenciais evocados somato-sensitivos em pacientes com mielopatia associada ao HTLV-1 1993
Aleitamento Materno e transmissão vertical do HIV-1 1993
Fatores de risco para infecções fúngicas disseminadas em pacientes neutropênicos: Estudo caso-controle 1993
Survival of HIV- 1 infected Brazilian individuals: a model based on the WHO staging system 1992
Urinary Tract Infection Is More Common In AIDS Patients Than In Asymptomatic HIV-infected Individuals, Or In Non-HIV Infected Patients. 1992
PPD Reactivity and Risk of Development of Tuberculosis in HIV Infected Brazilian Patients. 1992
Prevalence of Retroviral Infections in Intravenous Drug Users in Rio de Janeiro, Brazil 1992
Measurement of false-positive rate in a screening program for HIV-1 among 1398 patients with tuberculosis in Rio de Janeiro, Brazil 1992
Antigenic and genomic diversity of the HIV-1 V oop: Analysis of geographical variation by serology , neutralization and sequencing. 1992
Private versus state medical care of AIDS patients in Rio de Janeiro, Brasil: Impact on survival 1992
Parenteral behaviour and vertical transmission of HIV-1 in Rio de Janeiro, Brasil. 1992
NK activity in HIV infected brazilian individuals with different degrees of immune disfunction 1992
Predictors of CD4 counts in HIV-infected Brazilian individuals: A model based on the WHO staging system 1992
A prospective evaluation of 6 AIDS case definitions in Rio de Janeiro, Brazil. 1992
Predicao de contagem de CD4 nos individuos infectados pelo HIV 1992
Prevalencia de anticorpos para o virus da Hepatite C em populacoes de baixo e alto risco para doencas de transmissao sexual 1992
Impacto da infeccao pelo HTLV-1 em pacientes infectados pelo HIV-1. 1992
Atendimento publico X Atendimento privado: Impacto na sobrevida de pacientes com AIDS 1992
Tuberculose infeccao e doenca entre comunicantes de paciente com tuberculose pulmonar e infeccao pelo HIV. Estudo prospectivo: Resultados preliminares. 1992
Mielopatia associada a infeccao por HTLV-1: Experiencia do HUCFF-UFRJ 1992
L'impact des manifestations neurologiques sur la survie des patients bresiliens atteints par le SIDA 1991
Vertical and horizontal transmission of HTLV-1 in 4 generations of a brazilian family 1991
Predictors of pulmonary tuberculosis in sputum-negative brazilian AIDS patients 1991
Predictors of fungemia in AIDS patients: A case-control study 1991
Soroprevalencia de HIV-1 nas pueperas do Rio de Janeiro: resultados prelminares. VI Congresso Brasileiro de Infectologia 1991
Alteracoes eletroneuromiograficas associadas a infeccao pelo HTLV-1 numa familia brasileira 1991
Estudo eletroneuromiografico em 10 pacientes com mielopatia associada ao HTLV-1. 1991
Lepra como causa de resultados falso-positivos em testes sorologicos para deteccao de anticorpos anti-HIV. 1991
Transmissao vertical e horizontal de HTLV-1 em 4 geracoes de uma familia 1991
Manifestations neurologiques associees a l'infection par l'HTLV-1 chez une famille bresilienne. 1991
A pre-evaluation of a new, WHO-sponsored staging system for HIV infection 1990
A higher than expected frequency of Histoplasmosis : Importance of routine obtention of blood cultures for fungi. 1990
Criteria for presumptive diagnosis of neurotoxoplasmosis : Are they adequate? 1990
Comparative study of neurological complications in 172 cases of HIV infection 1990
Dermatological findings in patients with advanced HIV-related disease in Brazil. 1990
Achados dermatologicos nos pacientes com doenca relacionada ao HIV em estagios Avancados no Brasil 1990
AIDS e Miopatia 1990
Criterios para o diagnostico de neurotoxoplasmose: Serao adequados ? Revisao de 80 casos. 1990
Complicacoes Neurologicas da SIDA/AIDS Experiencia do HUCFF-UFRJ 1990
Possible high frequency of bacteriuria among brazilian AIDS patients 1990
Natural history of HIV infection in Brazil and other parts of the world: A proposal for a comparative study 1990
Differences In Kelling Of Cd4 Cells Induced By Hiv Isoletes From Asymptomatic And Aids Patients. 1989
Associacao de Diabetes Insipidus central e AIDS 1989
Descriptive analysis of Trypanosoma cruzi surface antigen profile: variations induced by different methodologies 1987
Quantitation Of A 72,000 Mw Cell Surface Glycoprotein In T.Cruzi Zymodernes And Detection Of Anti-Gp 72 Antibodies In Patients Carrying Different Zymodernes 1985
GP25 antigen of Trypanosoma cruzi: Identification of a 60 Kd precursor with monoclonal antibodies 1985
Characterization of a cross-reactive antigen of T. cruzi defined with Sleeping Sickness sera 1985
Involvement of carbohydrate structures in the antigenicity of T. cruzi glycoproteins GP25 and GP 50/55. 1985
Identification of T. cruzi glycoprotein GP 50/55 as a cross-reactive antigen of Trypanosomatids 1985
Propects For Species And Strain Specific Diagnoses Of T.Cruzi Infection. 1984
Monoclonal Antibodies Which Define A 72 K Glycoprotein And Tissue Cross Reacting Antigens In T.Cruzi. 1983
Publicações:
Minha Rede: